Lee Phillip E 4/A
4/A · Vaxart, Inc. · Filed May 11, 2023
Insider Transaction Report
Form 4/AAmended
Vaxart, Inc.VXRT
Lee Phillip E
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-17+45,000→ 113,750 total - Award
Common Stock
2023-03-17+56,652→ 170,402 total - Award
Stock Option (right to buy)
2023-03-17+205,000→ 205,000 totalExercise: $0.78Exp: 2033-03-16→ Common Stock (205,000 underlying)
Footnotes (3)
- [F1]This amendment is being filed to remove the grant of 90,000 shares of common stock that appeared in Table I, and to remove footnote 3 previously included on the Form 4 filed on March 21, 2023, due to an administrative error. Table I is fully restated to reflect the correct number of common stock held by the Reporting Person on March 17, 2023 to be 170,402. This amendment does not otherwise modify any transaction details that were previously reported in Table I on the Form 4.
- [F2]This amendment is also being filed to remove the grant of 410,000 shares of common stock in the form of stock options incorrectly reported on the Form 4 filed on March 21, 2023, due to an administrative error. Table II is fully restated to reflect the correct number of stock options held by the Reporting Person on March 17, 2023 to be 205,000, and to remove footnote 4 previously included on the Form 4 filed on March 21, 2023, due to an administrative error. This amendment does not otherwise modify any transaction details that were previously reported in Table II on the Form 4.
- [F3]The shares subject to this stock option shall fully vest on December 8, 2023.